Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission

Acta Psychiatrica Scandinavica

Volumn 101, Issue 4, 2000, Pages 274-280

  Krabbendam, L ^a   Honig, A ^a   Wiersma, J ^a   Vuurman, E F P M ^a   Hofman, P A M ^a   Derix, M M A ^a   Nolen, W A ^b   Jolles, J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Affective disorders; Cognition; Magnetic resonance imaging; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; MEMORY; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; WHITE MATTER;

BIPOLAR DISORDER; CEREBRAL VENTRICLES; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REMISSION INDUCTION; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 0034019729     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2000.101004274.x     Document Type: Article

References (52)

1. CROW TJ. The continuum of psychosis and its genetic origins: the sixty-fifth Maudsley lecture. Br J Psychiatry 1990;156:788-797.
2. TAYLOR MA. Are schizophrenia and affective disorder related? A selective literature review. Am J Psychiatry 1992;149:22-32.
3. HOFF AL, SHUKLA S, ARONSON T et al. Failure to differentiate bipolar disorder from schizophrenia on measures of neuropsychological function. Schizophr Res 1990;3:253-260.
4. ZIHL J, GRON G, BRUNNAUER A. Cognitive deficits in schizophrenia and affective disorders: evidence for a final common pathway disorder. Acta Psychiatr Scand 1998; 97:351-357.
5. GOLDBERG TE, GOLD JM, GREENBERG R et al. Contrasts between patients with affective disorders and patients with schizophrenia on a neuropsychological test battery. Am J Psychiatry 1993;150:1355-1362.
6. BULBENA A, BERRIOS GE. Cognitive function in the affective disorders: a prospective study. Psychopathology 1993;26: 6-12.
7. KRAEPELIN E. Dementia praecox and paraphrenia. Edinburgh: Livingstone, 1913.
8. COFFMAN JA, BORNSTEIN RA, OLSON SC, SCHWARZKOPF SB, NASRALLAH HA. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1990; 27:1188-1196.
9. MORICE R. Cognitive inflexibility and pre-frontal dysfunction in schizophrenia and mania. Br J Psychiatry 1990; 157:50-54.
10. VAN GORP WG, ALTSHULER L, THEBERGE DC, WILKINS J, DIXON W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 1998;55:41-46.
11. VIDEBECH P. MRI findings in patients with affective disorder: a meta-analysis. Acta Psychiatr Scand 1997;96: 157-168.
12. DUPONT RM, JERNIGAN TL, BUTTERS N et al. Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Clinical and neuropsychological significance. Arch Gen Psychiatry 1990;47:55-59.
13. SWAYZE VW, ANDREASEN NC, ALLIGER RJ, EHRHARDT JC, YUH WT. Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities. Arch Gen Psychiatry 1990;47:1054-1059.
14. PERSAUD R, RUSSOW H, HARVEY T et al. Focal signal hyperintensities in schizophrenia. Schizophr Res 1997;27: 55-64.
15. AWAD IA, SPETZLER RF, HODAK JA, AWAD CA, CAREY R. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly: I. Correlation with age and cerebrovascular risk factors. Stroke 1986;17:1090-1097.
16. SCHMIDT R, FAZEKAS F, OFFENBACHER H et al. Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol 1991;48:417-420.
17. DERIX MMA, JOLLES J. Neuropsychological abnormalities in depression: relation between brain and behaviour. In: HONIG A, VAN PRAAG HM, ed. Depression: neurobiological, psychopathological and therapeutic advances. Chichester: Wiley, 1997:109-126.
18. KING DA, CAINE ED. Cognitive impairment and major depression: beyond the pseudodementia syndrome. In: GRANT I, ADAMS KM, eds. Neuropsychological assessment of neuropsychiatric disorders, 2nd edn. Oxford: Oxford University Press, 1996:200-217.
19. GOUROVITCH ML, GOLDBERG TE. Cognitive deficits in schizophrenia: attention, executive functions, memory and language processing. In: PANTELIS C, NELSON HE, BARNES TRE, eds. Schizophrenia: a neuropsychological perspective. Chichester: Wiley, 1996:71-86.
20. SCHATZ J. Cognitive processing efficiency in schizophrenia: generalized vs domain specific deficits. Schizophr Res 1998; 30:41-49.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Press, 1994.
22. FIRST MB, SPITZER RL, WILLIAMS JBW, GIBBON M. Structured Clinical Interview for DSM-IV (SCID). Washington, DC: American Psychiatric Association, 1997.
23. World Health Organization. Composite International Diagnostic Interview (CIDI); Version 1.1. Geneva 1993.
24. DE BIE SE. Standaardvragen 1987: voorstellen voor uniformering van vraagstellingen naar achtergrondkenmerken en interviews [Standard questions 1987: proposal for uniformization of questions regarding background variables and interviews], 2nd edn. Leiden: Leiden University Press, 1987.
25. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
26. YOUNG RC, BIGGS JT, ZIEGLER VE, MEYER DA. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978;133:429-435.
27. OVERALL JE, GORHAM DE. The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
28. BRAND N, JOLLES J. Learning and retrieval rates of words presented auditorily and visually. J Gen Psychol 1985;112: 201-210.
29. STROOP JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935;18:643-662.
30. HOUX PJ, VREELING FW, JOLLES J. Age-associated cognitive decline is related to biological life-events. In: IQBAL K, MCLACHLAN DRC, WINBLAD B, WISNIEWSKI HM, eds. Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies. Chichester: Wiley, 1991:353-359.
31. REITAN RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Motor Skills 1958;8:271-276.
32. SMITH A. The Symbol Digit Modalities Test: a neuropsychological test for economic screening of learning and other cerebral disorders. Learn Disord 1968;36:83-91.
33. LEZAK MD. Neuropsychological assessment, 3rd edn. New York, Oxford: Oxford University Press, 1995.
34. LUTEIJN F, VAN DER PLOEG FAE. Handleiding Groninger Intelligentietest (GIT) [Manual Groningen Intelligence Test]. Lisse, The Netherlands: Swets & Zeitlinger, 1983.
35. ALBUS M, HUBMANN W, WAHLHEIM C, SOBIZACK N, FRANZ U, MOHR F. Contrasts in neuropsychological test profile between patients with first-episode schizophrenia and first-episode affective disorders. Acta Psychiatr Scand 1996;94:87-93.
36. HONIG A, ARTS BMG, PONDS RWHM, RIEDEL WJ. Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice. Int J Clin Psychopharmacol 1999;14:167-171.
37. PREVEY ML, DELANEY RC, CRAMER JA, CATTANACH L, COLLINS JF, MATTSON RH. Effects of valproate on cognitive functioning. Comparison with carbamazepine. Arch Neurol 1996;53:1008-1016.
38. DUNCAN JS, SHORVON SD, TRIMBLE MR. Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function. Epilepsia 1990;31:584-591.
39. VERMEULEN J, ALDENKAMP AP. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995;22:65-95.
40. DUPONT RM, BUTTERS N, SCHAFER K, WILSON T, HESSELINK J, GILLIN JC. Diagnostic specificity of focal white matter abnormalities in bipolar and unipolar mood disorder. Biol Psychiatry 1995;38:482-486.
41. BROWN FW, LEWINE RJ, HUDGINS PA, RISCH SC. White matter hyperintensity signals in psychiatric and nonpsychiatric subjects. Am J Psychiatry 1992;149:620-625.
42. STRAKOWSKI SM, WOODS BT, TOHEN M, WILSON DR, DOUGLASS AW, STOLL AL. MRI subcortical signal hyperintensities in mania at first hospitalization. Biol Psychiatry 1993;33:204-206.
43. 2 hyperintense foci on magnetic resonance images of schizophrenic patients and controls. Psychiatr Res Neuroimag 1991;40:239-245.
44. HARVEY I, RON M, DU BOULAY G, MURRAY R, LEWIS S. White matter abnormalities on magnetic resonance imaging in bipolar patients. Arch Gen Psychiatry 1990;47:1172-1173.
45. TUPLER LA, COFFEY CE, LOGUE PE, DJANG WT, FAGAN SM. Neuropsychological importance of subcortical white matter hyperintensity. Arch Neurol 1992;49:1248-1252.
46. FEIN G, VAN DYCKE C, DAVENPORT L et al. Preservation of normal cognitive functioning in elderly subjects with extensive white-matter lesions of long duration. Arch Gen Psychiatry 1990;47:220-223.
47. BOONE KB, MILLER BL, LESSER IM et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects: a threshold effect. Arch Neurol 1992;49:549-554.
48. FAZEKAS F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 1989;29:164-168.
49. DECARLI C, MURPHY DG, TRANH M et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-2084.
50. NASRALLAH HA. Neurodevelopmental aspects of bipolar affective disorder. Biol Psychiatry 1991;29:1-2.
51. POST RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149:999-1010.
52. ALTSHULER LL. Bipolar disorder: are repeated episodes associated with neuroanatomic and cognitive changes? Biol Psychiatry 1993;33:563-565.